Fumel B, Froment P, Holzenberger M, Livera G, Monget P, Fouchcourt S (2015) Expression of dominant-negative thyroid hormone receptor alpha1 in Leydig and Sertoli cells demonstrates no additional defect compared with expression in Sertoli cells only
Neurodegenerative disease potential Alzheimer's disease: May slow cognitive decline Protects cholinergic neurons (memory-critical) Reduces beta-amyloid toxicity (theoretical) Enhances neuroplasticity despite disease Not a cure but potential disease-modifying effect Parkinson's disease: Protects dopamine neurons in substantia nigra GDNF upregulation (critical for dopamine neurons) May slow motor symptom progression Supports brain resilience Used in Russian Parkinson's protocols Multiple sclerosis (MS): Neuroprotective for damaged neurons Supports myelin repair (theoretical) Reduces neuroinflammation May preserve cognitive function Part of comprehensive MS management Important caveats: Not a substitute: Continue conventional medical treatment Work with neurologist Pinealon as adjunct not replacement Part of comprehensive brain health strategy Learn about peptide therapy clinics and peptide safety
10.1016/j.bbrc.2011.09.046 Biochem
Although further clarification of the structure and mechanism related to the Na + -dependent glutathione transporter is needed, the synthetic skill and expertise in ligand identification, structure modification, and optimization of a medicinal chemist will undoubtedly facilitate the development of more diverse, potent, and effective glutathione transporter-based brain targeting ligands
O.KraussG
